Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 398

1.

Proteomic analysis of infiltrating ductal carcinoma tissues by coupled 2-D DIGE/MS/MS analysis.

Davalieva K, Kiprijanovska S, Broussard C, Petrusevska G, Efremov GD.

Mol Biol (Mosk). 2012 May-Jun;46(3):469-80.

PMID:
22888636
2.

Comparative proteome analysis of breast cancer and normal breast.

Luo Y, Zhang J, Liu Y, Shaw AC, Wang X, Wu S, Zeng X, Chen J, Gao Y, Zheng D.

Mol Biotechnol. 2005 Mar;29(3):233-44.

PMID:
15767701
3.

Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.

Ou K, Yu K, Kesuma D, Hooi M, Huang N, Chen W, Lee SY, Goh XP, Tan LK, Liu J, Soon SY, Bin Abdul Rashid S, Putti TC, Jikuya H, Ichikawa T, Nishimura O, Salto-Tellez M, Tan P.

J Proteome Res. 2008 Apr;7(4):1518-28. doi: 10.1021/pr700820g. Epub 2008 Mar 5.

PMID:
18318472
4.

High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast.

Somiari RI, Sullivan A, Russell S, Somiari S, Hu H, Jordan R, George A, Katenhusen R, Buchowiecka A, Arciero C, Brzeski H, Hooke J, Shriver C.

Proteomics. 2003 Oct;3(10):1863-73.

PMID:
14625848
5.

Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.

Zhang J, Song MQ, Zhu JS, Zhou Z, Xu ZP, Chen WX, Chen NW.

Int J Immunopathol Pharmacol. 2011 Oct-Dec;24(4):849-59.

PMID:
22230392
6.

Proteomic profiling of infiltrating ductal carcinoma reveals increased cellular interactions with tissue microenvironment.

Gormley M, Tchafa A, Meng R, Zhong Z, Quong AA.

J Proteome Res. 2012 Apr 6;11(4):2236-46. doi: 10.1021/pr201018y. Epub 2012 Mar 28.

PMID:
22356716
7.

Mass spectrometric characterization of protein structure details refines the proteome signature for invasive ductal breast carcinoma.

Röwer C, Koy C, Hecker M, Reimer T, Gerber B, Thiesen HJ, Glocker MO.

J Am Soc Mass Spectrom. 2011 Mar;22(3):440-56. doi: 10.1007/s13361-010-0031-6. Epub 2011 Feb 8.

PMID:
21472563
8.

Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues.

Sun W, Xing B, Sun Y, Du X, Lu M, Hao C, Lu Z, Mi W, Wu S, Wei H, Gao X, Zhu Y, Jiang Y, Qian X, He F.

Mol Cell Proteomics. 2007 Oct;6(10):1798-808. Epub 2007 Jul 12.

9.

Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.

Lai TC, Chou HC, Chen YW, Lee TR, Chan HT, Shen HH, Lee WT, Lin ST, Lu YC, Wu CL, Chan HL.

J Proteome Res. 2010 Mar 5;9(3):1302-22. doi: 10.1021/pr900825t.

PMID:
20052998
10.

Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancer.

Warmoes M, Jaspers JE, Pham TV, Piersma SR, Oudgenoeg G, Massink MP, Waisfisz Q, Rottenberg S, Boven E, Jonkers J, Jimenez CR.

Mol Cell Proteomics. 2012 Jul;11(7):M111.013334. doi: 10.1074/mcp.M111.013334. Epub 2012 Feb 24.

11.

Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE.

Raimondo F, Salemi C, Chinello C, Fumagalli D, Morosi L, Rocco F, Ferrero S, Perego R, Bianchi C, Sarto C, Pitto M, Brambilla P, Magni F.

Mol Biosyst. 2012 Apr;8(4):1040-51. doi: 10.1039/c2mb05390j. Epub 2012 Feb 8.

PMID:
22315040
12.

Proteomic analysis of breast cancer tissues to identify biomarker candidates by gel-assisted digestion and label-free quantification methods using LC-MS/MS.

Song MN, Moon PG, Lee JE, Na M, Kang W, Chae YS, Park JY, Park H, Baek MC.

Arch Pharm Res. 2012 Oct;35(10):1839-47. doi: 10.1007/s12272-012-1018-6. Epub 2012 Nov 9.

PMID:
23139137
13.

Isolation, identification and quantification of differentially expressed proteins from cancerous and normal breast tissues.

Othman MI, Majid MI, Singh M, Man CN, Lay-Harn G.

Ann Clin Biochem. 2008 May;45(Pt 3):299-306. doi: 10.1258/acb.2007.007104.

14.

Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.

Lee IN, Chen CH, Sheu JC, Lee HS, Huang GT, Yu CY, Lu FJ, Chow LP.

J Proteome Res. 2005 Nov-Dec;4(6):2062-9.

PMID:
16335951
15.

Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid.

Alexander H, Stegner AL, Wagner-Mann C, Du Bois GC, Alexander S, Sauter ER.

Clin Cancer Res. 2004 Nov 15;10(22):7500-10.

17.

Proteomics of breast carcinoma.

Somiari RI, Somiari S, Russell S, Shriver CD.

J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Feb 5;815(1-2):215-25. Review.

PMID:
15652811
18.

Breast cancer proteomics reveals a positive correlation between glyoxalase 1 expression and high tumor grade.

Fonseca-Sánchez MA, Rodríguez Cuevas S, Mendoza-Hernández G, Bautista-Piña V, Arechaga Ocampo E, Hidalgo Miranda A, Quintanar Jurado V, Marchat LA, Alvarez-Sánchez E, Pérez Plasencia C, López-Camarillo C.

Int J Oncol. 2012 Aug;41(2):670-80. doi: 10.3892/ijo.2012.1478. Epub 2012 May 14.

PMID:
22614840
19.

Proteome profiling of human epithelial ovarian cancer cell line TOV-112D.

Gagné JP, Gagné P, Hunter JM, Bonicalzi ME, Lemay JF, Kelly I, Le Page C, Provencher D, Mes-Masson AM, Droit A, Bourgais D, Poirier GG.

Mol Cell Biochem. 2005 Jul;275(1-2):25-55.

PMID:
16335783
20.

Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins.

Kim J, Kim SH, Lee SU, Ha GH, Kang DG, Ha NY, Ahn JS, Cho HY, Kang SJ, Lee YJ, Hong SC, Ha WS, Bae JM, Lee CW, Kim JW.

Electrophoresis. 2002 Dec;23(24):4142-56.

PMID:
12481271
Items per page

Supplemental Content

Write to the Help Desk